Sign in
CTSO Stock Price, Chart, Stats & News
Cytosorbents Corporation
Save
29.33M
Market cap
–
Current P/E
7.20x
Forward P/E
CTSO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 71.48% |
Operating margin | -38.89% |
Pretax margin | -23.20% |
Net margin | -22.12% |
Effective tax rate | 4.66% |
ROA | -18.56% |
ROE | -79.88% |
D/E | 4.93x |
Interest coverage ratio | -5.52x |
CTSO valuation
P/E | – |
P/S | 1.00x |
P/B | 6.31x |
P/CF | -3.76x |
P/FCF | -3.68x |
P/OCF | -3.76x |
PEG | -0.16x |
EV multiple | -1.08x |
About
Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorbent and porous polymer technology. The company's leading product, CytoSorb, is an extracorporeal filter designed to remove cytokines from the blood.
Similar securities
Based on sector and market capitalization
Report issue